1. Home
  2. FHTX vs POET Comparison

FHTX vs POET Comparison

Compare FHTX & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHTX
  • POET
  • Stock Information
  • Founded
  • FHTX 2015
  • POET 1972
  • Country
  • FHTX United States
  • POET Canada
  • Employees
  • FHTX N/A
  • POET N/A
  • Industry
  • FHTX Medicinal Chemicals and Botanical Products
  • POET Semiconductors
  • Sector
  • FHTX Health Care
  • POET Technology
  • Exchange
  • FHTX Nasdaq
  • POET Nasdaq
  • Market Cap
  • FHTX 237.4M
  • POET 401.2M
  • IPO Year
  • FHTX 2020
  • POET N/A
  • Fundamental
  • Price
  • FHTX $4.10
  • POET $4.77
  • Analyst Decision
  • FHTX Strong Buy
  • POET Strong Buy
  • Analyst Count
  • FHTX 6
  • POET 2
  • Target Price
  • FHTX $13.17
  • POET $6.25
  • AVG Volume (30 Days)
  • FHTX 110.9K
  • POET 2.0M
  • Earning Date
  • FHTX 03-06-2025
  • POET 03-14-2025
  • Dividend Yield
  • FHTX N/A
  • POET N/A
  • EPS Growth
  • FHTX N/A
  • POET N/A
  • EPS
  • FHTX N/A
  • POET N/A
  • Revenue
  • FHTX $25,515,000.00
  • POET $119,946.00
  • Revenue This Year
  • FHTX N/A
  • POET N/A
  • Revenue Next Year
  • FHTX $7.37
  • POET $9,744.96
  • P/E Ratio
  • FHTX N/A
  • POET N/A
  • Revenue Growth
  • FHTX N/A
  • POET N/A
  • 52 Week Low
  • FHTX $2.81
  • POET $1.00
  • 52 Week High
  • FHTX $10.25
  • POET $7.79
  • Technical
  • Relative Strength Index (RSI)
  • FHTX 38.20
  • POET 44.23
  • Support Level
  • FHTX $3.89
  • POET $4.00
  • Resistance Level
  • FHTX $4.64
  • POET $4.80
  • Average True Range (ATR)
  • FHTX 0.34
  • POET 0.38
  • MACD
  • FHTX 0.07
  • POET -0.06
  • Stochastic Oscillator
  • FHTX 30.77
  • POET 37.22

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.

Share on Social Networks: